Neurotech Vendors Incorporate VR in New Therapies
Several new and emerging manufacturers of neuromodulation systems have chosen to integrate extended reality (XR)—which encompasses virtual reality and augmented reality—into their new therapeutic approaches. The new strategies deliver indirect stimulation of the nervous system, utilizing the patient’s natural sensory pathways. Cognixion, a Santa Barbara, CA startup, recently raised $12 million in s…
Neurotech Vendors Incorporate VR in New Therapies
Several new and emerging manufacturers of neuromodulation systems have chosen to integrate extended reality (XR)—which encompasses virtual reality and augmented reality—into their new therapeutic approaches. The new strategies deliver indirect stimulation of the nervous system, utilizing the patient’s natural sensory pathways. Cognixion, a Santa Barbara, CA startup, recently raised $12 million in s…
Neurotech Reports Launches New Publication Serving Bioelectronic Medicine Industry
Neurotech Reports, the San Francisco, CA publisher of market intelligence for the healthcare industry, announced the launch of a new monthly newsletter covering the bioelectronic medicine industry, one of the newest and fastest growing industry segments. The publication, BioElectRx Business Report , is the first industry newsletter devoted to bioelectronic medicine, which refers to the therapeutic use of electrical or other forms of stimulation, rather than drugs, to treat disorders.
Neurotech Startup Founders and Executives to Present at 2021 Leaders Forum
Neurotech Reports, the publisher of this newsletter, updated the agenda for the 20th anniversary Neurotech Leaders Forum, which will take place in San Francisco on November 8-9, 2021. The event will also include speakers and attendees who prefer to participate via videoconference. Executives from several new and emerging neurotech firms will present at the conference. These include Brett Wingeier,…
Success and Excess
One of the major topics of debate at the 2021 Neurotech Leaders Forum, which took place earlier this month, was the question of whether the recent spate of success that the neuromodulation industry has seen in the last year or two was too much of a good thing. During an editorial panel featuring this editor, senior consulting editor Jeremy Koff, and contributing editor Jo Jo Platt, the panelists an…
Industry Professionals Counsel Emerging Entrepreneurs at NeuroDesign Workshop
Representatives from the neurotechnology industry, clinicians, and academics assembled with 32 students, post-docs, and neurotech entrepreneurs for the 2021 Cleveland NeuroDesign Entrepreneurs Workshop. The weekend event was held on the campus of Case Western Reserve University, which sponsored the workshop along with the Cleveland Clinic. The would-be entrepreneurs were grouped into eight teams of four and tasked with building a startup to address an unmet clinical need.
CMU Researchers Report New Cell-Targeted DBS
b y James Cavuoto, editor October 2021 issue One of the challenges confronting neural engineers developing enhanced DBS systems is prolonging the effect of the stimulation. This would not only lead to longer battery life and reduce the need for subsequent surgeries, it would also likely improve the efficacy of DBS therapy. A team of researchers at Carnegie Mellon University recently reported in Sci…
Building an Industry
As we prepare for the 20th anniversary Neurotech Leaders Forum next month, it’s fascinating to look back on how the neurotechnology industry has changed since the first Leaders Forum in 2001. That event, coming just a few weeks after the 9/11 attacks, was attended by about a dozen early neurotech professionals. Chief among the topics discussed at the inaugural meeting were what to call this new industry and what products would and wouldn’t be included.
Pain Management Specialists Discuss Clinical Trends at 2021 PSPS Conference
Nearly 600 pain management specialists from the fields of neurosurgery, orthopedics, rheumatology, neurology, psychiatry, and primary care came together in Las Vegas earlier this month for the Pacific Spine and Pain Society’s second annual meeting. This recently formed society was created to fill a niche in promoting collaboration between interventional pain management and spine physicians. The event, produced , took place at the Aria Hotel, with additional participation from online attendees.
Medtronic/Axonics Dispute Will Impact Future of SNS
The patent dispute between Medtronic and Axonics Modulation moved closer to resolution earlier this month as the U.S. Patent & Trademark Office offered decisions on the validity of the Medtronic patents. But the issue of infringement, and financial damages, if any, is still unresolved and awaiting a high-stakes trial that is likely to have a profound impact on the market for sacral nerve stimulation systems.